Improvement of nonalcoholic fatty liver disease by pig placenta extract (PPE) supplementation-Pilot study
Phase 1
Recruiting
- Conditions
- onalcoholic fatty liver disease
- Registration Number
- JPRN-jRCTs041210149
- Lead Sponsor
- Mutsumi Tsuchishima
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
1) Nonalcoholic fatty liver disease
2) Consent is obtained in writing
3) BMI: 25kg/m2 or more
4) Drinking amount: less than 20g/day (600g/month)
Exclusion Criteria
1) Those who are allergic to pig placenta preparations
2) Pregnant or nursing mothers
3) Patients with severe liver disease (decompensated cirrhosis: Child-Pugh grade C, Hepatocellular carcinoma)
4) Those who cannot ingest pigs religiously
5) Patients judged by the principal investigator or sub-investigator to be inappropriate as research subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method